Oral BPC-157 for Sale: What Is Actually Available

We went looking for oral BPC-157 products and found one listing and a lot of empty space. The capsule market for this peptide is thin. One seller has capsules on the page but none in stock. The other sells only vials. Here is the full picture, verified October 9, 2026, with no rounding and no guessing.

What Oral BPC-157 Products Exist

Real Peptides BPC-157 Capsules

Real Peptides lists a BPC-157 capsule product: 100 capsules, 500 mcg each, at a sale price of $120. The listing exists on their website. The product is currently out of stock. We checked multiple times over the past week and the status has not changed. The listing does not include a restock date. Real Peptides also sells a 10 mg lyophilized BPC-157 vial at $43.20, but that is an injectable-format product, not a capsule.

Peptide God - Vials Only

Peptide God sells BPC-157 exclusively as lyophilized powder in vials. The 5 mg vial is $34.95 ($6.99/mg) and the 10 mg vial is $59.95 ($6.00/mg). They also carry a BPC-157+TB500 blend at $59.95 (5 mg) and $99.95 (10 mg), plus standalone TB500 at $35.00 (5 mg) and $65.00 (10 mg). None of these are capsules or oral products.

Current Availability

The short version: if you specifically want oral BPC-157 capsules right now, neither seller can fill that order today. The Real Peptides capsule listing exists but cannot be purchased. Peptide God does not offer a capsule product at all.

Oral vs Injectable in Published Research

Most published BPC-157 studies use injection (intraperitoneal or subcutaneous) as the administration route. A smaller set of studies used oral gavage in animal models. No human bioavailability data exists for either route. The table below summarizes the general picture from published literature.

The oral gavage studies are notable because they show the peptide producing measurable effects when delivered through the GI tract in rats. However, oral gavage in a rat delivers the peptide directly to the stomach via a feeding tube, which is not the same as swallowing a capsule. Capsule dissolution, transit time, and the effect of stomach acid and digestive enzymes in humans remain unstudied for BPC-157.

How to Evaluate an Oral BPC-157 Product

Does the Label Say Capsule or Vial?

This distinction matters more than it might seem. We have seen buyers confuse lyophilized powder vials with oral products. A vial of BPC-157 from Peptide God or Real Peptides contains freeze-dried powder that is designed to be reconstituted with bacteriostatic water. The label on these products does not say "capsule" or "oral." If a product page says "lyophilized powder" or "reconstitute with bacteriostatic water," it is not an oral product. The injectable BPC-157 page covers what vial products are available and how they differ.

Is There a COA for Oral Purity?

A COA for a capsule product should test the finished capsule, not just the raw peptide powder before encapsulation. The process of mixing peptide with excipients, filling capsules, and storing them can all affect the amount of active peptide per unit. Real Peptides publishes lot-specific COAs with HPLC purity data (at least 99%) and endotoxin screening (less than 0.1 EU/mg) for their vial products, sourced from Freedom Diagnostics and Kovera. Whether the capsule product carries the same level of documentation is not clear from the listing, and since the capsules are out of stock, verification at checkout was not possible.

What Does the Research Say About Oral Stability?

BPC-157 is unusual among peptides in that animal studies have shown biological activity when administered orally via gavage. Most peptides degrade rapidly in the stomach. The published gavage data suggests BPC-157 retains some structural integrity through gastric transit in rats. That said, "some activity in rats via gavage" is a long way from "proven effective in humans via capsule." No human pharmacokinetic study has measured the oral bioavailability of BPC-157 in capsule form.

Regulatory Note